Literature DB >> 15760874

Reversible MR imaging abnormalities following cerebral venous thrombosis.

Carina Röttger1, Susan Trittmacher, Tibo Gerriets, Franz Blaes, Manfred Kaps, Erwin Stolz.   

Abstract

BACKGROUND AND
PURPOSE: Although rare, cerebral venous thrombosis (CVT) is being diagnosed more frequently owing to improved imaging techniques. The venous infarcts caused by CVT in 50% of patients are largely reversible and differ from arterial stroke. Our purpose was to study the time-dependent changes of venous infarcts on MR images and to define the variables that influence lesion volume in humans.
METHODS: MR images and venous angiograms were evaluated in 15 consecutive patients with venous infarcts due to CVT of sinus, cortical, or internal veins. All patients were treated with intravenous dose-adjusted heparin followed by oral anticoagulation for 12 months. Reduction of signal intensity changes on T1- and T2-weighted images was correlated to the degree of recanalization, age, initial absolute lesion size, and hemorrhage.
RESULTS: Within the first 30 days, we found a significant correlation between the volume of the lesion on T1-weighted images and recanalization. However, early recanalization did not influence the final lesion volume after 12 months. Eleven patients showed complete resolution of changes on T1- and T2-weighted images. Age of the patients influenced initial absolute volume of brain damage.
CONCLUSION: In venous stroke, even large parenchymal changes can resolve completely independent from recanalization of the thrombosed veins and sinuses. A plausible hypothesis is that venous infarcts largely consist of a persistent edema and that the lesion volume is influenced by the development of collateral veins. However, further investigations are necessary to understand the underlying abnormal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760874      PMCID: PMC7976480     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

1.  Cerebral venous thrombosis: correlation between recanalization and clinical outcome--a long-term follow-up of 40 patients.

Authors:  M Strupp; M Covi; K Seelos; M Dichgans; T Brandt
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

2.  Findings of magnetic resonance imaging in cerebral venous occlusion: difference from hemorrhagic infarction.

Authors:  Y Kurokawa; T Sohma; H Tsuchita; K Kitami; S Suzuki; M Ishiguro
Journal:  Comput Med Imaging Graph       Date:  1990 Nov-Dec       Impact factor: 4.790

3.  Diffusion-weighted mr in cerebral venous thrombosis.

Authors:  K O Lövblad; C Bassetti; J Schneider; R Guzman; M El-Koussy; L Remonda; G Schroth
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

4.  Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging.

Authors:  J Röther; K Waggie; N van Bruggen; A J de Crespigny; M E Moseley
Journal:  J Cereb Blood Flow Metab       Date:  1996-11       Impact factor: 6.200

5.  Diffusion-weighted MR imaging of an acute venous stroke: case report.

Authors:  E Peeters; T Stadnik; F Bissay; E Schmedding; M Osteaux
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

6.  Perfusion and diffusion magnetic resonance imaging in human cerebral venous thrombosis.

Authors:  C A Doege; R Tavakolian; C M Kerskens; B I Romero; R Lehmann; K M Einhäupl; A Villringer
Journal:  J Neurol       Date:  2001-07       Impact factor: 4.849

7.  Recanalisation of cerebral venous thrombosis.

Authors:  R W Baumgartner; A Studer; M Arnold; D Georgiadis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

Review 8.  [Value of cranial MRI in the follow-up of dural sinus thrombosis].

Authors:  J Bosch; A Rovira; J Alvarez-Sabín; J Capellades; S Abilleira; J Sumalla
Journal:  Rev Neurol       Date:  1998-06       Impact factor: 0.870

9.  Pathophysiological aspects of cerebral sinus venous thrombosis (SVT).

Authors:  A Villringer; S Mehraein; K M Einhäupl
Journal:  J Neuroradiol       Date:  1994-04       Impact factor: 3.447

10.  Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases.

Authors:  A B Brucker; H Vollert-Rogenhofer; M Wagner; K Stieglbauer; S Felber; J Trenkler; E Deisenhammer; F Aichner
Journal:  Cerebrovasc Dis       Date:  1998 Nov-Dec       Impact factor: 2.762

View more
  7 in total

1.  Unusual association of a pituitary adenoma and a neurological emergency: case report and diagnostic steps.

Authors:  Marina Baldini; Lorena Airaghi; Alessandra Orsatti; Alberto Tedeschi; Tiziana Ceraldi; Clara Sina; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2008-02-22       Impact factor: 3.397

Review 2.  Duration of anticoagulation after cerebral venous sinus thrombosis.

Authors:  Frances Caprio; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

Review 3.  Sinus thrombosis-do animal models really cover the clinical syndrome?

Authors:  Mesut Yenigün; Martin Jünemann; Tibo Gerriets; Erwin Stolz
Journal:  Ann Transl Med       Date:  2015-06

4.  Cerebral venous thrombosis: role of CT, MRI and MRA in the emergency setting.

Authors:  L Rizzo; S Greco Crasto; R Rudà; G Gallo; E Tola; D Garabello; R De Lucchi
Journal:  Radiol Med       Date:  2010-01-20       Impact factor: 3.469

5.  Histopathological effects of different therapy strategies in experimental sinus thrombosis.

Authors:  Erwin Stolz; Andrea Fett; Carina Wessels
Journal:  Neurol Sci       Date:  2014-03-14       Impact factor: 3.307

6.  Arachnoid granulations in the cerebral dural sinuses as demonstrated by contrast-enhanced 3D magnetic resonance venography.

Authors:  Azmi A Haroun; Waleed S Mahafza; Mahasen S Al Najar
Journal:  Surg Radiol Anat       Date:  2007-05-05       Impact factor: 1.354

7.  A Novel Mouse Model for Cerebral Venous Sinus Thrombosis.

Authors:  Marie-Charlotte Bourrienne; Stéphane Loyau; Sandro Benichi; Juliette Gay; Mialitiana Solo-Nomenjanahary; Clément Journé; Lucas Di Meglio; Aurélien Freiherr von Seckendorff; Jean-Philippe Desilles; Benoît Ho-Tin-Noé; Nadine Ajzenberg; Mikaël Mazighi
Journal:  Transl Stroke Res       Date:  2021-03-05       Impact factor: 6.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.